share_log

翰森製藥：截至二零二四年二月二十九日止月份之股份發行人的證券變動月報表

HANSOH PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

香港交易所 ·  Mar 1 05:18
Summary by Moomoo AI
翰森製藥集團有限公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年2月29日的情況。報告顯示，公司的法定/註冊股本及已發行股份在該月份均無變動，維持在20,000,000,000股，每股面值0.00001港元，總股本為200,000港元。此外，公司確認在該月份沒有發行新證券，並且所有相關的法律及規定要求均已遵守。報告中提及的零息可換股債券，於2021年1月22日發行，將於2026年到期，已發行總額為5,378,000美元，本月內無變動，並可能導致702,765新股份的發行。
翰森製藥集團有限公司於2024年3月1日向香港交易及結算所有限公司提交了最新的證券變動月報表，涵蓋截至2024年2月29日的情況。報告顯示，公司的法定/註冊股本及已發行股份在該月份均無變動，維持在20,000,000,000股，每股面值0.00001港元，總股本為200,000港元。此外，公司確認在該月份沒有發行新證券，並且所有相關的法律及規定要求均已遵守。報告中提及的零息可換股債券，於2021年1月22日發行，將於2026年到期，已發行總額為5,378,000美元，本月內無變動，並可能導致702,765新股份的發行。
HANSEN PHARMACEUTICAL GROUP LIMITED FILED ITS LATEST MONTHLY SECURITIES FLUCTUATION REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 1 MARCH 2024, COVERING THE SITUATION AS OF 29 FEBRUARY 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 20,000,000,000 shares with a face value of HK$0.00001 per share and a total share capital of HK$200,000. In addition, the Company confirms that no new securities were issued during the month and that all relevant legal and regulatory requirements have been complied with. The zero-yield convertible notes referred to in the report, issued on January 22, 2021 and due in 2026, have been issued for a total amount of $5,378,000, unchanged during the month and may result in the issuance of 702,765 new shares.
HANSEN PHARMACEUTICAL GROUP LIMITED FILED ITS LATEST MONTHLY SECURITIES FLUCTUATION REPORT WITH HONG KONG TRADING AND SETTLEMENT LIMITED ON 1 MARCH 2024, COVERING THE SITUATION AS OF 29 FEBRUARY 2024. The report shows that the company's regulated/registered share capital and issued shares remained unchanged during the month at 20,000,000,000 shares with a face value of HK$0.00001 per share and a total share capital of HK$200,000. In addition, the Company confirms that no new securities were issued during the month and that all relevant legal and regulatory requirements have been complied with. The zero-yield convertible notes referred to in the report, issued on January 22, 2021 and due in 2026, have been issued for a total amount of $5,378,000, unchanged during the month and may result in the issuance of 702,765 new shares.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more